UnitedHealth Group Incorporated (DE) (UNH) Financials

$375.21

$-0.05 (-0.01%)

As on 17-Sep-2026 16:28EDT

Market cap

$348,518 Mln

Revenue (TTM)

$450,129 Mln

P/E Ratio

25.2

P/B Ratio

3.6

Div. Yield

2.3 %

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Operating Revenue	450,129.00	447,567.00	400,278.00	371,622.00	324,162.00	287,597.00
Cost of Revenue	348,915.00	364,650.00	310,879.00	280,664.00	244,545.00	217,945.00
Gross Profit	101,214.00	82,917.00	89,399.00	90,958.00	79,617.00	69,652.00
Operating Expenses	79,538.00	63,953.00	57,112.00	58,600.00	51,182.00	45,682.00
Operating Profit (EBIT)	21,676.00	18,964.00	32,287.00	32,358.00	28,435.00	23,970.00
Other Income	--	--	--	--	--	--
Profit before Tax	17,440.00	14,697.00	20,071.00	29,112.00	26,343.00	22,310.00
Provision for Tax	2,528.00	1,890.00	4,829.00	5,968.00	5,704.00	4,578.00
Profit after Tax (Net Income)	14,122.00	12,056.00	14,405.00	22,381.00	20,120.00	17,285.00
Minority Interest	-790.00	-751.00	-837.00	-763.00	-519.00	-447.00
Consolidated Profit	2,358.00	12,056.00	14,405.00	22,381.00	20,120.00	17,285.00

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Shareholder's Funds	98,447.00	94,110.00	92,658.00	88,756.00	77,772.00	71,760.00
Minority Interest	-790.00	--	--	--	3,678.00	3,285.00
Non-Current Liabilities	91,958.00	92,986.00	91,918.00	80,442.00	70,121.00	57,435.00
Current Liabilities	111,820.00	114,897.00	103,769.00	99,054.00	89,237.00	78,292.00
Total Liabilities	421,547.00	309,581.00	298,278.00	273,720.00	245,705.00	212,206.00

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Non-Current Assets	222,867.00	218,999.00	212,499.00	195,283.00	176,636.00	150,448.00
Current Assets	86,860.00	90,582.00	85,779.00	78,437.00	69,069.00	61,758.00
Total Assets	421,547.00	309,581.00	298,278.00	273,720.00	245,705.00	212,206.00
Total Debt*	73,328.00	78,389.00	76,904.00	67,435.00	57,623.00	46,003.00
Net Current Assets	-24,960.00	-24,315.00	-17,990.00	-20,617.00	-20,168.00	-16,534.00

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Cash From Operating Activities	--	19,697.00	24,204.00	29,068.00	26,206.00	22,343.00
Cash Flow from Investing Activities	--	-8,685.00	-20,527.00	-15,574.00	-28,476.00	-10,372.00
Cash from Financing Activities	--	-11,644.00	-3,512.00	-11,529.00	4,226.00	-7,455.00
Net Cash Inflow / Outflow	--	--	--	--	1,956.00	-40,232.00

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Adjusted EPS ($)	15.54	13.25	15.54	23.94	21.25	18.10
Cash EPS ($)	--	18.04	19.96	28.19	24.84	21.35
Adjusted Book Value ($)	--	103.42	99.95	94.93	82.12	75.14
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	21.65	26.11	31.09	27.67	23.40
Free Cash Flow per Share ($)	--	17.66	22.34	27.47	24.71	20.83

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
ROCE (%)	--	7.05	8.84	15.35	15.90	15.25
ROE (%)	13.85	12.91	15.88	26.88	26.91	25.19
ROA (%)	3.36	3.97	5.04	8.62	8.79	8.44
EBIT Margin (%)	4.77	4.18	5.99	8.71	8.77	8.33
Net Margin (%)	3.14	2.69	3.60	6.02	6.21	6.01
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Revenue Growth (%)	6.46	0.12	0.08	0.15	0.13	0.12
EBIT Growth (%)	-30.03	-22.01	-25.90	13.80	18.63	6.99
Net Profit Growth (%)	-34.98	-16.31	-35.64	11.24	16.40	12.22
EPS Growth (%)	-32.69	-0.15	-0.35	0.13	0.17	0.13
Book Value Growth (%)	4.39	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Price / Earnings	25.25	24.92	32.55	21.99	24.95	27.74
Price / Book Value	3.58	3.19	5.06	5.55	6.46	6.68
Dividend Yield (%)	2.28	--	--	--	--	--
EV/EBITDA	15.41	15.21	18.40	14.59	16.70	18.53
Close Price ($)	415.63	330.11	505.86	526.47	530.18	502.14
High Price ($)	427.93	606.36	630.73	554.70	558.10	509.23
Low Price ($)	234.60	234.60	436.38	445.68	445.74	320.35
Market Cap ($ Cr)	348,518.12	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Debt to Equity	0.71	0.83	0.83	0.76	0.74	0.64
Short term debt to equity ratio	0.04	0.06	0.05	0.06	0.04	0.05
Current Ratio	0.78	0.79	0.83	0.79	0.77	0.79
Quick Ratio	0.78	--	--	1.48	--	--
Interest Coverage	5.48	4.67	6.14	9.97	13.59	14.44

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Debtors to sales (%)	10.28	11.78	12.11	10.49	9.39	9.76
Asset Turnover	1.07	1.47	1.40	1.43	1.42	1.40
Receivable days	--	41.28	39.89	34.11	32.98	26.00
Inventory Days	--	--	-80.60	-89.27	--	--
Payable days	--	73.09	59.05	57.73	79.08	78.34
Cash Conversion Cycle	--	--	-99.76	-112.89	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Income Statement ($ Mln)